Segui
Valentino Conti
Titolo
Citata da
Citata da
Anno
Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: systematic review of observational studies
G Roberto, E Raschi, C Piccinni, V Conti, L Vignatelli, R D’Alessandro, ...
Cephalalgia 35 (2), 118-131, 2015
1612015
Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy
G Corrao, V Conti, L Merlino, AL Catapano, G Mancia
Clinical therapeutics 32 (2), 300-310, 2010
1192010
Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation
G Corrao, A Zambon, V Conti, F Nicotra, C La Vecchia, C Fornari, ...
Annals of oncology 19 (1), 150-155, 2008
912008
Antipsychotic drug exposure and risk of venous thromboembolism: a systematic review and meta-analysis of observational studies
C Barbui, V Conti, A Cipriani
Drug safety 37, 79-90, 2014
832014
Paediatric drug use with focus on off-label prescriptions in Lombardy and implications for therapeutic approaches
C Carnovale, V Conti, V Perrone, S Antoniazzi, M Pozzi, L Merlino, ...
European journal of pediatrics 172, 1679-1685, 2013
512013
Safety profile of the direct oral anticoagulants: an analysis of the WHO database of adverse drug reactions
L Monaco, C Biagi, V Conti, M Melis, M Donati, M Venegoni, A Vaccheri, ...
British journal of clinical pharmacology 83 (7), 1532-1543, 2017
502017
Paroxysmal sympathetic hyperactivity in pediatric rehabilitation: clinical factors and acute pharmacological management
M Pozzi, V Conti, F Locatelli, S Galbiati, S Radice, G Citerio, E Clementi, ...
The Journal of Head Trauma Rehabilitation 30 (5), 357-363, 2015
472015
Seriousness, preventability, and burden impact of reported adverse drug reactions in Lombardy emergency departments: a retrospective 2-year characterization
V Perrone, V Conti, M Venegoni, S Scotto, L Degli Esposti, D Sangiorgi, ...
ClinicoEconomics and outcomes research, 505-514, 2014
442014
Cost-effectiveness of enhancing adherence to therapy with statins in the setting of primary cardiovascular prevention. Evidence from an empirical approach based on …
G Corrao, L Scotti, A Zambon, G Baio, F Nicotra, V Conti, S Capri, ...
Atherosclerosis 217 (2), 479-485, 2011
412011
One-year follow up of asthmatic patients newly initiated on treatment with medium-or high-dose inhaled corticosteroid-long-acting β2-agonist in UK primary care settings
R Buhl, LG Heaney, E Loefroth, M Larbig, K Kostikas, V Conti, H Cao
Respiratory medicine 162, 105859, 2020
362020
Persistence with pharmacological treatment in the specialist mental healthcare of patients with severe mental disorders
V Conti, A Lora, A Cipriani, I Fortino, L Merlino, C Barbui
European journal of clinical pharmacology 68, 1647-1655, 2012
342012
Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions
C Biagi, V Conti, N Montanaro, M Melis, E Buccellato, M Donati, ...
European journal of clinical pharmacology 70, 1505-1512, 2014
322014
Adequacy of treatment for patients with schizophrenia spectrum disorders and affective disorders in Lombardy, Italy
A Lora, V Conti, O Leoni, AL Rivolta
Psychiatric Services 62 (9), 1079-1084, 2011
312011
Antipsychotic drug exposure and risk of pulmonary embolism: a population-based, nested case–control study
V Conti, M Venegoni, A Cocci, I Fortino, A Lora, C Barbui
BMC psychiatry 15, 1-7, 2015
292015
Ethnic differences in the utilization of mental health services in Lombardy (Italy): an epidemiological analysis
F Spinogatti, G Civenti, V Conti, A Lora
Social psychiatry and psychiatric epidemiology 50, 59-65, 2015
282015
Differences in COPD exacerbation risk between women and men: analysis from the UK clinical practice research datalink data
D Stolz, K Kostikas, E Loefroth, R Fogel, FS Gutzwiller, V Conti, H Cao, ...
Chest 156 (4), 674-684, 2019
252019
Adherence to generic v. brand antidepressant treatment and the key role of health system factors
C Barbui, V Conti
Epidemiology and psychiatric sciences 24 (1), 23-26, 2015
252015
Paroxysmal sympathetic hyperactivity in pediatric rehabilitation: pathological features and scheduled pharmacological therapies
M Pozzi, V Conti, F Locatelli, S Galbiati, S Radice, E Clementi, S Strazzer
The Journal of Head Trauma Rehabilitation 32 (2), 117-124, 2017
232017
Use of antipsychotic drugs and mood stabilizers in women of childbearing age with schizophrenia and bipolar disorder: epidemiological survey
C Barbui, V Conti, M Purgato, A Cipriani, I Fortino, AL Rivolta, A Lora
Epidemiology and psychiatric sciences 22 (4), 355-361, 2013
182013
Management of paroxysmal sympathetic hyperactivity with dexmedetomidine and propranolol following traumatic brain injury in a pediatric patient
JW Branstetter, KL Ohman, DW Johnson, BW Gilbert
Journal of Pediatric Intensive Care 9 (01), 064-069, 2020
162020
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20